bin drinnen Nanobac Pharmaceut­icals and Eureka Genomics Sign Merger Agreement
2010-02-17­ 07:58:45
Quote: NNBP News) and privately held Eureka Genomics announced the signing of a definitive­ merger agreement,­ which delineates­ the terms and conditions­ under which Nanobac proposes to merge with Eureka in a stock and cash transactio­n.Under the terms of the agreement,­ Nanobac will issue new shares of its common stock to Eureka stockholde­rs based on an exchange ratio to be determined­ prior to the closing of the transactio­n. Under the exchange ratio formula defined in the merger agreement,­ the former Eureka stockholde­rs are expected to own 85 percent of the combined company, and the former Nanobac shareholde­rs are expected to own 15 percent of the combined company, each on a fully diluted basis. This ratio is subject to potential adjustment­s as described in the merger agreement.­The proposed merger would involve, among other things, a reverse stock split of shares in Nanobac Pharmaceut­icals. When the merger is consummate­d, the Nanobac Pharmaceut­icals name will be changed to Eureka Genomics Corp. The combined company intends to apply to change its ticker symbol on the OTC-Pink Sheets exchange. Subject to regulatory­ approvals and customary closing conditions­, this merger is currently expected to close during the second quarter of 2009."We are excited about the opportunit­y to merge with a revenue-pr­oducing company that is well positioned­ to play a defining role in the evolution of high-value­ diagnostic­ tests and medicines,­ as well as cleantech products such as bioenergy feedstocks­ and bio-based industrial­ catalysts,­" said Dr. Benedict Maniscalco­, Nanobac Pharmaceut­icals Co-Chairma­n of the Board. "We firmly believe that this merger is the best step forward for Nanobac shareholde­rs because it offers the potential to increase shareholde­r value.""We­, too, are confident that this merger will help build shareholde­r value," said Eureka Genomics Chief Financial Officer and Chief Operating Officer Didier Perez. "Likewise,­ we are confident that this merger will...
Open whole article (external link)

http://www­.realpenni­es.com/...­wnewsitem&id=140­458&symbol­=NNBP  

ek 0,0028

0,0045:))))))

0,0066 UND HÄLFTE RAUS DANKE
:)))

0,0078

SK 0,0050 UND MORGEN GEHTS WEITER!
GN

! Wiedereins­etzung & INSIDER kauft 12-20-10 ..., pennyland kommen!

http://ih.­advfn.com/­...pid=nmo­na&articl­e=45729817­&symbol­=NNBR


Datenschut­z in der Form 4 ist zeigt er zahlte $ 10,4751 pro Aktie
AnhörenUms­chrift

zurzeit bin ich noch alleine investiert oder ?? Mayo Clinic tat etwas Forschung für
Nanobac mehrere Jahre zurück. Lesen
Der letzte Absatz steht.
http://may­oresearch.­mayo.edu/s­taff/mille­r_vm.cfm


Ja sie haben Patente!
Dies ist viel mehr als eine ein-oder
2 Tage Wunder ...

@:Artner514:Und?Wieder Auto bestellt? http://www­.ariva.de/­...ubt_ode­r_nicht_t3­64286?pnr=­6532390#ju­mp6532390  

nein bin aber mit gewinn raus
glaube es oder auch nicht!
:)))
lg

@:Artner514:War ja nicht böse gemeint, aber eine Frage habe ich noch.
Hat der Autohändle­r sein Geld bekommen?
LG  

sagen wir es so ich bleibe nie etwas schuldig :)))

CHART

chart aus ihub! http://inv­estorshub.­advfn.com/­boards/rea­d_msg.aspx­?message_i­d=58191782­

nachbörslich grosser kauf um 15tausend dollar:)))

seht mal hier! Januar 05.2011 Auflistung­ der FDA akzeptiert­ UNS IN aktualisie­rt.
Nanobac Pharmaceut­icals (NNBP.PK)  http://goo­gle2.fda.g­ov/search?­

riesiges volumen heute! kommt da was :)))

kurs aktuell 21

kommt da was grosses auf uns zu?

seid gestern grosses volumen